Page last updated: 2024-08-26

yttrium radioisotopes and Leukopenia

yttrium radioisotopes has been researched along with Leukopenia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Izumitani, S; Matsuo, H; Saeki, Y; Sakurashita, H; Taogoshi, T; Yoshikawa, H	1
Adams, GP; Axworthy, D; Breitz, H; Bryan, K; Colcher, D; Fisher, DR; Gaffigan, S; Gentner, L; Goris, ML; Horak, ID; Knox, SJ; Tempero, M; Weiden, PL; Weiner, LM	1
Austin, JC; Gerstbrein, J; Kahn, D; Maguire, RT; Miller, SJ; Williams, RD	1

Trials

2 trial(s) available for yttrium radioisotopes and Leukopenia

Article	Year
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:2 Topics: Adult; Aged; Anemia; Antibodies, Monoclonal; Biotin; Colonic Neoplasms; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Radioimmunotherapy; Radiopharmaceuticals; Thrombocytopenia; Yttrium Radioisotopes	2000
A phase II study of [90Y] yttrium-capromab pendetide in the treatment of men with prostate cancer recurrence following radical prostatectomy. Cancer biotherapy & radiopharmaceuticals, 1999, Volume: 14, Issue:2 Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Marrow; Combined Modality Therapy; Edetic Acid; Gonadotropin-Releasing Hormone; Humans; Immunoconjugates; Leukopenia; Male; Middle Aged; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiation Injuries; Radioimmunodetection; Salvage Therapy; Soft Tissue Neoplasms; Thrombocytopenia; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome; Yttrium Radioisotopes	1999

Article

Year

Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:2

Topics: Adult; Aged; Anemia; Antibodies, Monoclonal; Biotin; Colonic Neoplasms; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Radioimmunotherapy; Radiopharmaceuticals; Thrombocytopenia; Yttrium Radioisotopes

2000

A phase II study of [90Y] yttrium-capromab pendetide in the treatment of men with prostate cancer recurrence following radical prostatectomy.

Cancer biotherapy & radiopharmaceuticals, 1999, Volume: 14, Issue:2

Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Marrow; Combined Modality Therapy; Edetic Acid; Gonadotropin-Releasing Hormone; Humans; Immunoconjugates; Leukopenia; Male; Middle Aged; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiation Injuries; Radioimmunodetection; Salvage Therapy; Soft Tissue Neoplasms; Thrombocytopenia; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome; Yttrium Radioisotopes

1999

Other Studies

1 other study(ies) available for yttrium radioisotopes and Leukopenia

Article	Year
Safety of Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2019, Volume: 139, Issue:1 Topics: Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Asian People; Female; Humans; Japan; Leukopenia; Lymphoma; Male; Middle Aged; Neutropenia; Radiopharmaceuticals; Retrospective Studies; Safety; Thrombocytopenia; Treatment Outcome; Yttrium Radioisotopes	2019